LCM
BCTX

Lynwood Capital Management’s Briacell Therapeutics BCTX Stock Holding History

Lynwood Capital Management’s Portfolio BCTX Stock Details BCTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$4.57M Buy
2023
Q4 		$9.25M Sell
2023
Q3 		$9.89M Sell
2023
Q2 		$10.2M Buy
2023
Q1 		$11.4M Hold
2022
Q4 		$6.69M Buy
2022
Q3 		$6.73M Buy
2022
Q2 		$3.55M Sell
2022
Q1 		$7.61M Sell
2021
Q4 		$6.5M Buy